BeyondSpring Inc. Interest Expense
BeyondSpring Inc. (BYSI) reported Interest Expense of $0 for the 6-month period ending 2023-06-30, per its 6-K filed 2024-02-02.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-02-02
- BeyondSpring Inc. interest expense for the quarter ending 2021-12-31 was $21.00K, a 4.55% decline year-over-year.
- BeyondSpring Inc. interest expense for the quarter ending 2021-09-30 was $20.00K, a 4.76% decline year-over-year.
- BeyondSpring Inc. interest expense for the quarter ending 2021-06-30 was $22.00K, a 4.76% increase year-over-year.
- BeyondSpring Inc. interest expense for the quarter ending 2021-03-31 was $24.00K, a 14.29% increase year-over-year.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 6-K · filed 2024-02-02 | |||
| 2022-12-31 | $17.00K 20-F · filed 2023-04-18 | |||
| 2022-06-30 | $17.00K 6-K · filed 2024-02-02 | |||
| 2021-12-31 | $21.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $41.00K derived: sum of 2 quarters · filed 2023-04-18 | $63.00K derived: sum of 3 quarters · filed 2023-04-18 | $87.00K 20-F · filed 2023-04-18 |
| 2021-09-30 | $20.00K 6-K · filed 2021-12-30 | $42.00K derived: sum of 2 quarters · filed 2021-12-30 | $66.00K 6-K · filed 2021-12-30 | $88.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-06-30 | $22.00K 6-K · filed 2021-09-10 | $46.00K 6-K · filed 2023-02-28 | $68.00K derived: sum of 3 quarters · filed 2023-04-18 | $89.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-03-31 | $24.00K 6-K · filed 2021-06-16 | $46.00K derived: sum of 2 quarters · filed 2023-04-18 | $67.00K derived: sum of 3 quarters · filed 2023-04-18 | $88.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2020-12-31 | $22.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $43.00K derived: sum of 2 quarters · filed 2023-04-18 | $64.00K derived: sum of 3 quarters · filed 2023-04-18 | $85.00K 20-F · filed 2023-04-18 |
| 2020-09-30 | $21.00K 6-K · filed 2021-12-30 | $42.00K derived: sum of 2 quarters · filed 2021-12-30 | $63.00K 6-K · filed 2021-12-30 | $83.00K derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-06-30 | $21.00K 6-K · filed 2021-09-10 | $42.00K 6-K · filed 2021-09-10 | $62.00K derived: sum of 3 quarters · filed 2022-04-14 | $108.00K derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-03-31 | $21.00K 6-K · filed 2021-06-16 | $41.00K derived: sum of 2 quarters · filed 2022-04-14 | $87.00K derived: sum of 3 quarters · filed 2022-04-14 | $190.00K derived: sum of 4 quarters · filed 2022-04-14 |
| 2019-12-31 | $20.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $66.00K derived: sum of 2 quarters · filed 2022-04-14 | $169.00K derived: sum of 3 quarters · filed 2022-04-14 | $206.00K 20-F · filed 2022-04-14 |
| 2019-09-30 | $46.00K 6-K · filed 2020-11-17 | $149.00K derived: sum of 2 quarters · filed 2020-11-17 | $186.00K 6-K · filed 2020-11-17 | |
| 2019-06-30 | $103.00K 6-K · filed 2020-09-03 | $140.00K 6-K · filed 2020-09-03 | ||
| 2019-03-31 | $37.00K 6-K · filed 2020-06-11 | |||
| 2015-12-31 | $532.00K 20-F · filed 2018-04-03 | |||
| 2014-12-31 | $826.00K 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |